<?xml version="1.0" encoding="UTF-8"?>
<ref id="psb1843-bib-0040">
 <label>40</label>
 <mixed-citation publication-type="book" id="psb1843-cit-0040">
  <string-name>
   <surname>Chen</surname>
   <given-names>C</given-names>
  </string-name>, 
  <italic>et al</italic> Favipiravir versus arbidol for COVID‚Äê19: a randomized clinical trial. 
  <italic>medRxiv</italic>
  <year>2020</year>; 
  <source xml:lang="en">15 April. DOI</source>: 
  <pub-id pub-id-type="doi">10.1101/2020.03.17.20037432</pub-id>. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.03.17.20037432v2" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.medrxiv.org/content/10.1101/2020.03.17.20037432v2</ext-link>
 </mixed-citation>
</ref>
